OXT and type 2 diabetes mellitus: Finally, only one clinical study, by Akour et al., aimed to evaluate the differences in oxytocin plasma levels and their potential association with inflammatory and anti-inflammatory markers in diabetic (MetS-T2DM), prediabetic (MetS-prediabetics), and non-diabetic with metabolic syndrome (MetS-only) patients.